Myotonic dystrophy protein kinase monoclonal antibody generation from a coiled‐coil template

Myotonic dystrophy protein kinase (DMPK) was the initial representative of a ubiquitous protein kinase family that regulates cell size and shape. DMPK is highly expressed in heart and skeletal muscle and transgenic over‐expression induces cardiac hypertrophy. The characterization of DMPK has been limited by the paucity of immunological reagents with high affinity and well‐defined specificity. Amino acid sequence data was used to predict the surface exposure of the coil‐coiled domain of DMPK. These exposed amino acids were substituted into an extremely stable coiled‐coil template to produce a peptide antigen. Sera from mice immunized with the peptide conjugated to keyhole limpet hemocyanin were screened against recombinant DMPK using Western blots. Murine spleens expressing DMPK antibodies were used to produce hybridoma cell lines. Hybridoma supernatants were further screened against recombinant DMPK and four clonal hybridoma cell lines expressing DMPK antibodies were generated. These four monoclonal antibodies recognized recombinant DMPK in Western blots of COS‐1 cell lysates expressing high levels of recombinant DMPK and immunoprecipitated recombinant DMPK from COS‐1 cell lysates. The identity of the immunoprecipitated DMPK was confirmed by MALDI‐TOF mass spectrometry and peptide mass fingerprinting. DMPK was the only protein detected in the immunoprecipitates, indicating the high specificity of the antibodies. Western blots immunostained with two of the monoclonal antibodies specifically recognized the two isoforms of endogenous DMPK, DMPK‐1 and DMPK‐2, that are expressed at low levels in the human heart. The recognition of low amounts of DMPK‐1 and DMPK‐2 indicates the high affinity of these antibodies. A human heart lysate was subjected to ammonium sulfate precipitation and column chromatography to produce a fraction that was enriched in DMPK. One of the monoclonal antibodies immunoprecipitated endogenous DMPK from this fraction. This antibody was used for immuno‐localization studies of an adenoviral DMPK construct, expressed in adult mouse cardiac myocytes. This construct was localized to the intercalated disc, the site of endogenous DMPK, indicating that this antibody is applicable to immuno‐localization studies. This study demonstrates the utility of the described procedure for generation of specific monoclonal antibodies with high affinity for epitopes in coiled‐coiled domains of mammalian proteins expressed at low levels. Copyright © 2006 John Wiley & Sons, Ltd.

[1]  W. Kingston.  Myotonic Dystrophy, 2nd Ed. , 1990, Neurology.

[2]  R. Moxley,et al.  Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene , 1997, Nature Genetics.

[3]  STABLECOIL: An Algorithm Designed to Predict the Location and Relative Stability of Coiled-Coils in Native Protein Sequences , 2001 .

[4]  G. Morris,et al.  Localization of myotonic dystrophy protein kinase in human and rabbit tissues using a new panel of monoclonal antibodies. , 1998, Human molecular genetics.

[5]  Y. Kino,et al.  Overexpression of human myotonic dystrophy protein kinase in Schizosaccharomyces pombe induces an abnormal polarized and swollen cell morphology. , 2003, Journal of biochemistry.

[6]  M. Fardaei,et al.  Myotonic dystrophy—a multigene disorder , 2001, Brain Research Bulletin.

[7]  T. Cooper,et al.  Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. , 1998, Science.

[8]  David E. Housman,et al.  Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member , 1992, Cell.

[9]  T. Ashizawa,et al.  RNA CUG Repeats Sequester CUGBP1 and Alter Protein Levels and Activity of CUGBP1* , 2001, The Journal of Biological Chemistry.

[10]  R. Korneluk,et al.  Myotonic dystrophy (DM) protein kinase levels in congenital and adult DM patients , 2000, European Journal of Human Genetics.

[11]  T. Ashizawa,et al.  An unstable triplet repeat in a gene related to myotonic muscular dystrophy. , 1992, Science.

[12]  P. Harper,et al.  Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. , 2002, Human molecular genetics.

[13]  M. Somerville,et al.  Characterization of myotonic dystrophy kinase (DMK) protein in human and rodent muscle and central nervous tissue. , 1995, Human molecular genetics.

[14]  Santiago Reyes,et al.  Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy. , 2004, Human molecular genetics.

[15]  S. Naylor,et al.  Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9 , 2001, Science.

[16]  C. Amemiya,et al.  Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. , 1992, Science.

[17]  W. DeGrado,et al.  Use of 2,2′-dithiobis(5-nitropyridine) for the heterodimerization of cysteine containing peptides. Introduction of the 5-nitro-2-pyridinesulfenyl group , 1996 .

[18]  D. Housman,et al.  Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy , 1996, Nature Genetics.

[19]  C. Mant,et al.  Effects of side-chain characteristics on stability and oligomerization state of a de novo-designed model coiled-coil: 20 amino acid substitutions in position "d". , 2000, Journal of molecular biology.

[20]  T. Cooper,et al.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy , 2001, Nature Genetics.

[21]  S. Tapscott,et al.  Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP , 1997, Nature Genetics.

[22]  Pierre Lavigne,et al.  The role of position a in determining the stability and oligomerization state of α‐helical coiled coils: 20 amino acid stability coefficients in the hydrophobic core of proteins , 2008, Protein science : a publication of the Protein Society.

[23]  A. Berns,et al.  Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice , 1996, Nature Genetics.

[24]  B. Wieringa,et al.  Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties. , 2000, Human molecular genetics.

[25]  R. Hodges,et al.  A de Novo Designed Template for Generating Conformation-specific Antibodies That Recognize α-Helices in Proteins* , 2002, The Journal of Biological Chemistry.

[26]  D. Biral,et al.  Identification and localization of the myotonic dystrophy gene product in skeletal and cardiac muscles. , 1994, Biochemical and biophysical research communications.

[27]  B. Wieringa,et al.  Alternative Splicing Controls Myotonic Dystrophy Protein Kinase Structure, Enzymatic Activity, and Subcellular Localization , 2003, Molecular and Cellular Biology.

[28]  K. Suzuki,et al.  Novel isoform of myotonin protein kinase: gene product of myotonic dystrophy is localized in the sarcoplasmic reticulum of skeletal muscle. , 1997, The American journal of pathology.

[29]  D. Housman,et al.  Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues , 1995, The Journal of cell biology.

[30]  R. P. Junghans,et al.  RNA Leaching of Transcription Factors Disrupts Transcription in Myotonic Dystrophy , 2004, Science.

[31]  L. Ranum,et al.  Myotonic dystrophy: Clinical and molecular parallels between myotonic dystrophy type 1 and type 2 , 2002, Current neurology and neuroscience reports.

[32]  H. F. Epstein,et al.  Homodimerization through coiled‐coil regions enhances activity of the myotonic dystrophy protein kinase , 2003, FEBS letters.

[33]  S. Helmke,et al.  Myotonic dystrophy protein kinase domains mediate localization, oligomerization, novel catalytic activity, and autoinhibition. , 2000, Biochemistry.